CUSIP: 05360L304
Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,150,820
-
Share change
-
+826,509
-
Total reported value
-
$168,933
-
Price per share
-
$0.15
-
Number of holders
-
13
-
Value change
-
+$120,033
-
Number of buys
-
8
-
Number of sells
-
6
Quarterly Holders Quick Answers
What is CUSIP 05360L304?
CUSIP 05360L304 identifies ATXI - AVENUE THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2024
-
Previous quarter:
Q4 2023
Recent filing periods for CUSIP 05360L304:
Institutional Holders of AVENUE THERAPEUTICS INC - COM (ATXI) as of Q1 2024
As of 31 Mar 2024,
AVENUE THERAPEUTICS INC - COM (ATXI) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,150,820 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, TWO SIGMA SECURITIES, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, HRT FINANCIAL LP, STATE STREET CORP, JANE STREET GROUP, LLC, MILLENNIUM MANAGEMENT LLC, and Tower Research Capital LLC (TRC).
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.